DMA Group delivers a comprehensive pharmaceutical portfolio designed to support disease prevention, treatment efficiency, and performance optimization across poultry and livestock operations. Our range includes high-efficacy antimicrobials, antiparasitics, anti-inflammatory agents, respiratory support solutions, and metabolic enhancers, all selected based on proven field performance and international quality standards.
Our pharmaceutical line covers critical therapeutic categories including antibiotics (e.g. oxytetracycline, florfenicol, amoxicillin, doxycycline), anticoccidials (diclazuril, toltrazuril), antiparasitics (ivermectin, closantel), and respiratory agents (bromhexine, tylosin-based solutions), ensuring effective control of bacterial, parasitic, and systemic infections.
In addition, DMA provides combination formulations and advanced injectable solutions that enhance bioavailability, reduce treatment duration, and improve recovery outcomes under intensive production conditions. Our portfolio also includes vitamin complexes, electrolyte solutions, and metabolic support products designed to stabilize animals during stress, disease challenge, and production transitions.
All products are sourced from reputable international manufacturers and are supported by strict quality control, ensuring consistency in active ingredient concentration, stability, and field efficacy. Through continuous technical support and on-site consultation, DMA ensures that pharmaceutical solutions are applied correctly, maximizing therapeutic success while supporting responsible and efficient use.
We collaborate with internationally recognized manufacturers to bring high-quality veterinary and agricultural products to the Iraqi market.
With decades of experience, DMA Group has built a trusted reputation among farms, feed mills, and veterinary professionals across Iraq.
Implementation of eco-friendly lighting technologies.
Implementing sustainable solutions to reduce energy use and costs.
.png){kind=small}
.svg)
%20(1).webp)